MedDataX Logo

Primary Care in AURA for COVID-19

NCT ID: NCT05124145

Last Updated: 2021-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-01

Study Completion Date

2021-11-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As few data are available on the epidemiology of the COVID-19 in primary care, the project aims to implement a practice-based surveillance network based on multiprofessional health homes in the French region Auvergne-Rhône-Alpes (Aura), able to monitor the evolution of the current epidemic.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Care : Suspected and Confirmed Cases of COVID-19 Primary Health Care COVID-19 Pandemic

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COVID-19 Primary care Clinical epidemiology Practice assessment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

surveillance network

The surveillance network is made of 200 health professionals from 85 practices

No intervention (surveillance system)

Intervention Type OTHER

The surveillance network will collect data on all consecutive COVID-19 cases

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention (surveillance system)

The surveillance network will collect data on all consecutive COVID-19 cases

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Suspect or confirmed COVID-19 case consulting in primary care in the Aura region

Exclusion Criteria

* Patient with a COVID-19 diagnosis excluded after clinical examination or investigation.
* Patient refusing to participate to the study
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Research on Healthcare Performance Lab U1290

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laurent LETRILLART, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Research on Healthcare Performance Lab U1290

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

RESHAPE

Lyon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SOPRAC

Identifier Type: -

Identifier Source: org_study_id